Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

Pharmaceutical and cosmetics manufacturer safeguards serialization of prescription medicines

SCHLIEREN, Switzerland – April 22, 2021 – Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front line of business with solutions and partners that deliver a performance edge, today announced Swiss pharmaceutical and cosmetics manufacturer, Louis Widmer SA is using its flexible serialization solution for its packaging line. Zebra® PartnerConnect Registered Reseller and Independent Software Vendor (ISV), BetterTec deployed the solution to help Louis Widmer SA rapidly comply with the European Union (EU) Falsified Medicines Directive.

The recent EU directive calls for all prescription medicines in Europe to be packaged with 2D barcodes and anti-tamper devices which pharmacists have to scan and authenticate in a system of record. To fulfill this legal requirement, Louis Widmer SA implemented a high-speed serialization solution. It is comprised of Zebra’s Android™ ET50 tablets and MP7000 bioptic scanners along with BetterTec’s serialization software to scan, record and activate its prescription medicines’ serial numbers as well as apply tamper evidence.

“We now have a semi-automated, stand-alone system to help ensure our compliance with the EU Falsified Medicines Directive,” said David Oelsner, Manager GMP Compliance & Quality Assurance, Louis Widmer SA. “The collaboration of Zebra and BetterTec with high-performance devices and customizable serialization software provides great value for pharmaceutical manufacturing companies, like us, who are looking for a user-friendly, reliable and flexible solution.”

Louis Widmer SA successfully implemented the serialization solution without any major changes to its existing systems. With its modular design, the solution can be quickly integrated or removed from the packaging line when Louis Widmer SA’s front-line workers are processing other products, since prescription medicine represents a fraction of its product portfolio.

“We are delighted we were able to deploy this solution in such a short timeframe,” said Philipp Johannesson, VP and Sales director DACH, Zebra Technologies. “The easy-to-use Zebra touch computers and accurate bioptic scanners help Louis Widmer meet its EU compliance requirements.”


  • Louis Widmer SA selected Zebra’s ET50 tablets and MP7000 bioptic scanners with BetterTec’s software to comply with the EU’s anti-counterfeiting regulations for prescription medicine.
  • The high-speed serialization solution was designed to function as an independent system, providing the flexibility required when the packaging line is used for different pharmaceutical and cosmetics products.
  • Learn more about Louis Widmer SA by reading the case study.


Zebra (NASDAQ: ZBRA) empowers the front line in retail/ecommerce, manufacturing, transportation and logistics, healthcare, public sector and other industries to achieve a performance edge. With more than 10,000 partners across 100 countries, Zebra delivers industry-tailored, end-to-end solutions to enable every asset and worker to be visible, connected and fully optimized. The company’s market-leading solutions elevate the shopping experience, track and manage inventory as well as improve supply chain efficiency and patient care. In 2020, Zebra made Forbes Global 2000 list for the second consecutive year and was listed among Fast Company’s Best Companies for Innovators. For more information, visit www.zebra.com or sign up for news alerts. Participate in Zebra’s Your Edge blog, follow the company on LinkedIn, Twitter and Facebook, and check out our Story Hub: Zebra Perspectives.

ZEBRA and the stylized Zebra head are trademarks of Zebra Technologies Corp., registered in many jurisdictions worldwide. Android is a trademark of Google LLC. All other trademarks are the property of their respective owners. ©2021 Zebra Technologies Corp. and/or its affiliates.